Semin Arthritis Rheum. 2023 Feb 10;59:152177. doi: 10.1016/j.semarthrit.2023.152177. Online ahead of print. ABSTRACT OBJECTIVE: Disease-modifying anti-rheumatic drugs (DMARDs) that treat rheumatoid arthritis (RA) may reduce
Nat Biotechnol. 2023 Jan 2. doi: 10.1038/s41587-022-01566-x. Online ahead of print. ABSTRACT Identification of CD8+ T cell epitopes is critical for the development of immunotherapeutics.
Immunother Adv. 2022 Nov 25;2(1):ltac022. doi: 10.1093/immadv/ltac022. eCollection 2022. NO ABSTRACT PMID:36530352 | PMC:PMC9749131 | DOI:10.1093/immadv/ltac022
Sci Immunol. 2022 Apr 21:eabl9464. doi: 10.1126/sciimmunol.abl9464. Online ahead of print. ABSTRACT CD4+ T cells are central to long-term immunity against viruses through the functions
Nat Genet. 2022 Jul 14. doi: 10.1038/s41588-022-01113-z. Online ahead of print. ABSTRACT The chr12q24.13 locus encoding OAS1-OAS3 antiviral proteins has been associated with coronavirus disease
Sci Immunol. 2022 May 12:eabp8328. doi: 10.1126/sciimmunol.abp8328. Online ahead of print. ABSTRACT Key features of immune memory are greater and faster antigen-specific antibody responses to
bioRxiv. 2022 Apr 28:2022.04.28.489772. doi: 10.1101/2022.04.28.489772. Preprint. ABSTRACT The Omicron subvariant BA.2 has become the dominant circulating strain of severe acute respiratory syndrome coronavirus 2
Sci Immunol. 2022 May 10:eabo3425. doi: 10.1126/sciimmunol.abo3425. Online ahead of print. ABSTRACT Neutralizing antibodies that recognize the SARS-CoV-2 spike glycoprotein are the principal host defense
Cell Rep. 2022 Apr 26;39(4):110729. doi: 10.1016/j.celrep.2022.110729. Epub 2022 Apr 11. ABSTRACT The Omicron variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), bearing an
Clin Lab Med. 2022 Mar;42(1):85-96. doi: 10.1016/j.cll.2021.10.004. Epub 2021 Nov 3. ABSTRACT Severe acute respiratory syndrome coronavirus 2 (COVID)-19 has emerged as the greatest global